169 related articles for article (PubMed ID: 3729200)
21. Idiosyncratic toxicity associated with potentiated sulfonamides in the dog.
Trepanier LA
J Vet Pharmacol Ther; 2004 Jun; 27(3):129-38. PubMed ID: 15189298
[TBL] [Abstract][Full Text] [Related]
22. Acetylator phenotyping in patients with malignant lymphomas, using caffeine as the metabolic probe.
William BM; Abdel-tawab AM; Hassan EA; Mohamed OF
Pol J Pharmacol; 2004; 56(4):445-9. PubMed ID: 15520499
[TBL] [Abstract][Full Text] [Related]
23. An in vitro study of the microsomal metabolism and cellular toxicity of phenytoin, sorbinil and mianserin.
Riley RJ; Maggs JL; Lambert C; Kitteringham NR; Park BK
Br J Clin Pharmacol; 1988 Nov; 26(5):577-88. PubMed ID: 3207562
[TBL] [Abstract][Full Text] [Related]
24. Sulfonamide acetylation in isolated rat liver cells.
Olsen H; Mørland J
Acta Pharmacol Toxicol (Copenh); 1981 Aug; 49(2):102-9. PubMed ID: 7336968
[TBL] [Abstract][Full Text] [Related]
25. Caffeine acetylator phenotyping during maturation in infants.
Pariente-Khayat A; Pons G; Rey E; Richard MO; D'Athis P; Moran C; Badoual J; Olive G
Pediatr Res; 1991 May; 29(5):492-5. PubMed ID: 1896253
[TBL] [Abstract][Full Text] [Related]
26. Nitrofurantoin cytotoxicity. In vitro assessment of risk based on glutathione metabolism.
Spielberg SP; Gordon GB
J Clin Invest; 1981 Jan; 67(1):37-41. PubMed ID: 7451657
[TBL] [Abstract][Full Text] [Related]
27. Drug metabolite toxicity assessed in human lymphocytes with a purified, reconstituted cytochrome P-450 system.
Leeder JS; Cannon M; Nakhooda A; Spielberg SP
J Pharmacol Exp Ther; 1988 Jun; 245(3):956-62. PubMed ID: 3385648
[TBL] [Abstract][Full Text] [Related]
28. In-vitro assessment of a hypersensitivity syndrome associated with sorbinil.
Spielberg SP; Shear NH; Cannon M; Hutson NJ; Gunderson K
Ann Intern Med; 1991 May; 114(9):720-4. PubMed ID: 2012352
[TBL] [Abstract][Full Text] [Related]
29. Hypersensitivity of HIV-1-infected cells to reactive sulfonamide metabolites correlated to expression of the HIV-1 viral protein tat.
Arp J; Rieder MJ; Urquhart B; Freeman D; Tucker MJ; Krizova A; Lehmann D; Dekaban GA
J Pharmacol Exp Ther; 2005 Sep; 314(3):1218-25. PubMed ID: 15933158
[TBL] [Abstract][Full Text] [Related]
30. Differential toxicity of reactive metabolites of clindamycin and sulfonamides in HIV-infected cells: influence of HIV infection on clindamycin toxicity in vitro.
Wijsman JA; Dekaban GA; Rieder MJ
J Clin Pharmacol; 2005 Mar; 45(3):346-51. PubMed ID: 15703369
[TBL] [Abstract][Full Text] [Related]
31. In vitro analysis of metabolic predisposition to drug hypersensitivity reactions.
Riley RJ; Leeder JS
Clin Exp Immunol; 1995 Jan; 99(1):1-6. PubMed ID: 7813099
[TBL] [Abstract][Full Text] [Related]
32. In vitro assessment of pharmacogenetic susceptibility to toxic drug metabolites in humans.
Spielberg SP
Fed Proc; 1984 May; 43(8):2308-13. PubMed ID: 6714438
[TBL] [Abstract][Full Text] [Related]
33. Caffeine metabolism in a healthy Spanish population: N-acetylator phenotype and oxidation pathways.
Carrillo JA; Benítez J
Clin Pharmacol Ther; 1994 Mar; 55(3):293-304. PubMed ID: 8143395
[TBL] [Abstract][Full Text] [Related]
34. Stimulation of human T cells with sulfonamides and sulfonamide metabolites.
Castrejon JL; Berry N; El-Ghaiesh S; Gerber B; Pichler WJ; Park BK; Naisbitt DJ
J Allergy Clin Immunol; 2010 Feb; 125(2):411-418.e4. PubMed ID: 20159253
[TBL] [Abstract][Full Text] [Related]
35. Improving the diagnosis of hypersensitivity reactions associated with sulfonamides.
Lanctôt KL; Ghajar BM; Shear NH; Naranjo CA
J Clin Pharmacol; 1994 Dec; 34(12):1228-33. PubMed ID: 7738220
[TBL] [Abstract][Full Text] [Related]
36. Mechanisms of drug reactions: the metabolic track.
Shapiro LE; Shear NH
Semin Cutan Med Surg; 1996 Dec; 15(4):217-27. PubMed ID: 9069589
[TBL] [Abstract][Full Text] [Related]
37. Aminopyrine metabolism in man: the acetylation of aminoantipyrine cosegregates with acetylation of caffeine.
Agúndez JA; Carrillo JA; Martínez C; Benítez J
Ther Drug Monit; 1995 Feb; 17(1):1-5. PubMed ID: 7725368
[TBL] [Abstract][Full Text] [Related]
38. Analysis of the Metabolic Pathway of Bosentan and of the Cytotoxicity of Bosentan Metabolites Based on a Quantitative Modeling of Metabolism and Transport in Sandwich-Cultured Human Hepatocytes.
Matsunaga N; Kaneko N; Staub AY; Nakanishi T; Nunoya K; Imawaka H; Tamai I
Drug Metab Dispos; 2016 Jan; 44(1):16-27. PubMed ID: 26502773
[TBL] [Abstract][Full Text] [Related]
39. Interactions of glucose-6-phosphate dehydrogenase deficiency with drug acetylation and hydroxylation reactions.
Magon AM; Leipzig RM; Zannoni VG; Brewer GJ
J Lab Clin Med; 1981 Jun; 97(6):764-70. PubMed ID: 7229511
[TBL] [Abstract][Full Text] [Related]
40. N-acetyltransferase 2 polymorphism in patients infected with human immunodeficiency virus.
Kaufmann GR; Wenk M; Taeschner W; Peterli B; Gyr K; Meyer UA; Haefeli WE
Clin Pharmacol Ther; 1996 Jul; 60(1):62-7. PubMed ID: 8689813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
